Comparative Effectiveness Research
The Comparative Effectiveness Analysis of Surgery And Radiation (CEASAR) study compares surgery, radiation and active surveillance for management of localized prostate cancer.
The CEASAR study is a population-based, longitudinal, prospective cohort study that began in 2011. It has received funding from the Agency for Healthcare Research and Quality, the Patient-Centered Outcomes Research Institute and the National Cancer Institute.
Selected Comparative Effectiveness Research Publications
Learn more about our work related to comparative effectiveness:
- Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years
- Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam With Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer
- The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples
- Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer
- Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer